Relationship between ID1 and EGFR-TKI Resistance 
in Non-small Cell Lung Cancer

Relationship between ID1 and EGFR-TKI Resistance 
in Non-small Cell Lung Cancer

Background and objective Non-small cell lung cancer (NSCLC) presents the highest morbidity and mortality among malignant tumors worldwide. The overall effective rate of epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) is 30% to 40%, and PFS (progression-free sruvival) is 12 mont...

Full description

Bibliographic Details
Main Authors: Yuchen BAO, Yinmin ZHAO, Bin CHEN, Jie LUO, Qinfang DENG, Hui SUN, Boxiong XIE, Songwen ZHOU
Format: Article
Language:zho
Published: Chinese Anti-Cancer Association; Chinese Antituberculosis Association 2016-12-01
Series:Chinese Journal of Lung Cancer
Subjects:
Lung neoplasms
ID1
EGFR-TKI
Drug resistance
Online Access:http://dx.doi.org/10.3779/j.issn.1009-3419.2016.12.10

Internet

http://dx.doi.org/10.3779/j.issn.1009-3419.2016.12.10

Similar Items